There is a high unmet medical need regarding extensive-disease small-cell lung cancer (SCLC) that shows poor outcomes with median OS of 9 to 11 months. First-line chemotherapy usually evokes marked responses, but responders typically experience only limited periods of disease control. Read more ...
10.10.2017 | Onkologie | Online-Artikel